Peptides DB

Research-centric peptide and protocol reference hub

BPC-157

Research-centric overview

Share
Peptide

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Community effect votes, structured logs, and side-effect summaries.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Healing & recovery 4.3/5 · Muscle & body comp 3.3/5 · Metabolic & appetite 2.3/5 · Neuro & mood 3.0/5 · Sleep & circadian 0.7/5 · Inflammation & immune 4.0/5 · Skin & aesthetics 2.0/5Healing 4.3Muscle 3.3Metabolic 2.3Neuro 3.0Sleep 0.7Inflammation 4.0Skin 2.0

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

Pain / discomfort+2/5
Sleep / recovery+2/5
Performance / output+1/5

Based on 10 anonymized research logs. Scroll down for full context and methodology.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

48%improved healing
24%flushing
19%vivid dreams
5%nausea
3%anxiety

Research footprint

Last analyzed Jun 2, 2026
6
Studies indexed
1
Human
0
Animal
6
AI analyzed
Evidence mix17% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2023–2026
Librarian pulse — latest actionsFull changelog ↓
  • Jun 2, 5:00 PMRe-scoredScored effects for BPC-157
  • Jun 2, 5:00 PMVerifiedVerified content for BPC-157: accurate
  • Jun 1, 7:01 AMVerifiedVerified content for BPC-157: accurate

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source.Clinical TrialClinicalTrials.govPublished Oct 1, 2015Added Apr 16, 2026

This study assessed the safety and pharmacokinetics of PCO-02, which contains BPC-157, in healthy volunteers. The specifics of the dosing regimen and the outcomes measured are not detailed in the abstract. No therapeutic claims are made regarding the effects of BPC-157.

Phase: PHASE1Status: UNKNOWN
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRIClinical TrialClinicalTrials.govPublished Feb 2, 2026Added Apr 16, 2026

This study measured the effects of pentadecapeptide BPC 157 on the repair of acute grade II hamstring strains confirmed by MRI. The trial was a randomized, double-blind, placebo-controlled phase 2 study. Specific outcomes and numeric results are not reported in the abstract.

Phase: PHASE2Status: RECRUITING
Semantic Scholar search for BPC-157StudySemanticScholarAdded Dec 12, 2025

Not reported in abstract.

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.StudyPubMedPublished Jan 1, 2023Added Dec 12, 2025

This review discusses BPC-157's potential in musculoskeletal healing but lacks original data to support its claims.

BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185.StudyPubMedPublished Jan 1, 2025Added Dec 12, 2025

Not reported in abstract.

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185".StudyPubMedPublished Jan 1, 2025Added Dec 12, 2025

The commentary discusses BPC-157's potential roles in angiogenesis and nitric oxide modulation, but lacks specific findings to support its claims.

Popular stacks

Most commonly stacked peptides based on community research logs.

TB-500 (Thymosin Beta-4)
8x
GHK-Cu
5x
Glow Stack (BPC-157 + TB-500 + GHK-Cu)
3x

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Community notes

No comments yet. Share research notes, citations, or observations below.

Comments appear immediately.

Community research logs (detail)

Showing the latest 5 logs out of 10.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

Goal: injury / tissue repair

Context: recreational • 26-35

Duration ~8.0 weeks • ~7.0 doses/week

Δ scores
Pain +3Sleep +1Perf +2

Knee tendon discomfort after heavy training block. Combined with progressive PT 3x/week and sleep/nutrition focus.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

Goal: injury / tissue repair

Context: recreational • 26-35

Duration ~8.0 weeks • ~7.0 doses/week

Δ scores
Pain +3Sleep +1Perf +2

Knee tendon discomfort after heavy training block. Combined with progressive PT 3x/week and sleep/nutrition focus.

Goal: general repair / longevity

Context: sedentary / light • 36-45

Duration ~4.0 weeks • ~5.0 doses/week

Δ scores
Pain +1Sleep +2Perf +0

Diffuse joint stiffness and sleep quality tracked. Also added walking and basic mobility work.

How to read these logs

Each entry is a single, anonymized “n=1” summary with relative change sliders from −5 to +5. Higher positive values indicate perceived improvement; negative values indicate perceived worsening.

Context (training level, age band, duration, and dosing frequency) is shown so you can quickly skim for patterns or outliers. Treat this as qualitative signal layered on top of study data, not as a substitute for controlled trials.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Quick tone breakdown of submitted side-effect tags:

PositiveNegativeNeutral / mixed

Top reported tags so far (color reflects tone):

48%improved healing
24%flushing
19%vivid dreams

Librarian Changelog

Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.

0m agoScoring70%

Scored effects for BPC-157

0m agoVerificationai-researcher90%

Verified content for BPC-157: accurate

1d agoVerificationai-researcher90%

Verified content for BPC-157: accurate

May 26Scoring70%

Scored effects for BPC-157

May 26task_runlibrarian-runner

Completed task: Find real articles for BPC-157 (thin literature)

May 26Ingestiondiscovery

Searched for real articles on BPC-157

May 26Refreshai-researcher85%

Refreshed content for BPC-157

Apr 16Refreshai-researcher80%

Refreshed content for BPC-157